Derivatives of sulindac, use thereof and preparation thereof

  • US 9,365,528 B2
  • Filed: 03/30/2012
  • Issued: 06/14/2016
  • Est. Priority Date: 04/01/2011
  • Status: Expired due to Fees
First Claim
Patent Images

1. A compound represented by the formula:

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×